Justin Yang | Advisor
Global Health Investment Corporation

Justin Yang, Advisor, Global Health Investment Corporation

Justin Yang is an accomplished entrepreneur and executive in government, biotech, and life sciences. He co-founded DMV Bio and Kaibab Health, firms that launch biotechnology companies focused on global health security. At Lyndra Therapeutics, as Chief of Staff and Head of Corporate Development, he led a $100 million non-dilutive portfolio for advanced oral drug delivery platforms targeting diseases like HIV and malaria. Previously, as Director at BARDA, he initiated BARDA Ventures, a $250 million fund to expedite medical countermeasures. Justin’s investment activities include forming BARDA Ventures and advising on capital formation and portfolio strategy. Additionally, he holds board positions, including with Rockville Economic Development, and actively engages with companies like Neoclease. His career is marked by leadership in developing innovative healthcare solutions.

Appearances:



Main Congress Day 2 - 23rd April @ 17:10

Panel: Private investment – what are VCs looking for before they commit?

Examples of vaccine biotechs striking a successful partnership with emerging markets

last published: 22/Apr/25 15:25 GMT

back to speakers